Syndax Pharmaceuticals (SNDX) Operating Margin Growth (5y) (2020 - 2026)
Syndax Pharmaceuticals (SNDX) Operating Margin Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Syndax Pharmaceuticals | 1.83 Bn | 1.48 Bn | 53.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 711,429.00 |
| Dec 31, 2025 | 513,531.00 |
| Sep 30, 2025 | 511,307.00 |
| Jun 30, 2025 | 419,988.00 |
| Mar 31, 2025 | 356,626.00 |
| Dec 31, 2024 | 248,341.00 |
| Sep 30, 2024 | 275,278.00 |
| Jun 30, 2024 | 193,601.00 |
| Dec 31, 2021 | 372,843.00 |
| Sep 30, 2021 | 483,419.00 |
| Jun 30, 2021 | -306,206.00 |
| Mar 31, 2021 | -429,718.00 |
| Dec 31, 2020 | -369,222.00 |
| Sep 30, 2020 | -331,760.00 |
| Jun 30, 2020 | 2.82 Mn |